Hot TME is characterized by a high tumor mutational burden (TMB), high neo antigens expression, high type 1 interferon (INF-I) production mainly linked to the STING pathway, high CD8+ T lymphocytes infiltration (TLI), and high dendritic cell (DCs) activation and cross-presentation. The gene discussed is STING1; the disease is neoplasm.